Episode 203: Non-Rx Consumer Skincare

Looking to stay ahead in the evolving world of skincare? We've got just the insights you need. This week, we're joined by Daniel Winn as we explore the advancements in bioavailable prodrugs and the expanding clinical skincare segment. Listen in as we dive into the science behind these innovations and what they mean for the future of consumer skincare. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.

 

Daniel Winn, PhD has spent several decades commercializing cosmetic ingredients for the global beauty industry. He’s held a series of positions at global raw material companies where he led transformational efforts in green chemistry, and the development of new anti-microbial agents as safer & gentler preservatives for topical products. In 2018 he founded Actera Ingredients, a startup whose goal was to advance the science and efficacy of active agents for skincare and hair repair. Dan is the inventor or co-inventor of several patents, and has a PhD in Chemical Engineering from the University of Massachusetts Amherst.

 

Sponsored by Actera

Visit Actera's website for more information.